Suppr超能文献

危重病会诱导脂肪组织中 M2 巨噬细胞的交替激活。

Critical illness induces alternative activation of M2 macrophages in adipose tissue.

机构信息

Laboratory and Department of Intensive Care Medicine, K.U.Leuven, Herestraat 49, 3000 Leuven, Belgium.

出版信息

Crit Care. 2011;15(5):R245. doi: 10.1186/cc10503. Epub 2011 Oct 21.

Abstract

INTRODUCTION

We recently reported macrophage accumulation in adipose tissue of critically ill patients. Classically activated macrophage accumulation in adipose tissue is a known feature of obesity, where it is linked with increasing insulin resistance. However, the characteristics of adipose tissue macrophage accumulation in critical illness remain unknown.

METHODS

We studied macrophage markers with immunostaining and gene expression in visceral and subcutaneous adipose tissue from healthy control subjects (n = 20) and non-surviving prolonged critically ill patients (n = 61). For comparison, also subcutaneous in vivo adipose tissue biopsies were studied from 15 prolonged critically ill patients.

RESULTS

Subcutaneous and visceral adipose tissue biopsies from non-surviving prolonged critically ill patients displayed a large increase in macrophage staining. This staining corresponded with elevated gene expression of "alternatively activated" M2 macrophage markers arginase-1, IL-10 and CD163 and low levels of the "classically activated" M1 macrophage markers tumor necrosis factor (TNF)-α and inducible nitric-oxide synthase (iNOS). Immunostaining for CD163 confirmed positive M2 macrophage staining in both visceral and subcutaneous adipose tissue biopsies from critically ill patients. Surprisingly, circulating levels and tissue gene expression of the alternative M2 activators IL-4 and IL-13 were low and not different from controls. In contrast, adipose tissue protein levels of peroxisome proliferator-activated receptor-γ (PPARγ), a nuclear receptor required for M2 differentiation and acting downstream of IL-4, was markedly elevated in illness. In subcutaneous abdominal adipose tissue biopsies from surviving critically ill patients, we could confirm positive macrophage staining with CD68 and CD163. We also could confirm elevated arginase-1 gene expression and elevated PPARγ protein levels.

CONCLUSIONS

Unlike obesity, critical illness evokes adipose tissue accumulation of alternatively activated M2 macrophages, which have local anti-inflammatory and insulin sensitizing features. This M2 macrophage accumulation may contribute to the previously observed protective metabolic activity of adipose tissue during critical illness.

摘要

简介

我们最近报道了危重病患者脂肪组织中巨噬细胞的积累。在肥胖症中,脂肪组织中经典激活的巨噬细胞积累是众所周知的特征,它与胰岛素抵抗的增加有关。然而,危重病中脂肪组织巨噬细胞积累的特征尚不清楚。

方法

我们使用免疫染色和基因表达研究了来自健康对照受试者(n=20)和非存活延长危重病患者(n=61)的内脏和皮下脂肪组织中的巨噬细胞标志物。为了比较,还研究了 15 名延长危重病患者的皮下活体脂肪组织活检。

结果

非存活延长危重病患者的皮下和内脏脂肪组织活检显示巨噬细胞染色大量增加。这种染色与“替代性激活”M2 巨噬细胞标志物精氨酸酶-1、IL-10 和 CD163 的基因表达升高以及“经典激活”M1 巨噬细胞标志物肿瘤坏死因子(TNF)-α和诱导型一氧化氮合酶(iNOS)的低水平相对应。免疫染色 CD163 证实了危重病患者的内脏和皮下脂肪组织活检中 M2 巨噬细胞的阳性染色。令人惊讶的是,替代 M2 激活物 IL-4 和 IL-13 的循环水平和组织基因表达均较低,与对照组无差异。相比之下,核受体 PPARγ(M2 分化所必需的)的脂肪组织蛋白水平在疾病中显著升高,它是 IL-4 的下游靶标。在存活的延长危重病患者的皮下腹部脂肪组织活检中,我们可以用 CD68 和 CD163 证实阳性的巨噬细胞染色。我们还可以证实精氨酸酶-1 基因表达升高和 PPARγ 蛋白水平升高。

结论

与肥胖症不同,危重病会引起脂肪组织中替代性激活的 M2 巨噬细胞的积累,这些细胞具有局部抗炎和胰岛素敏化的特征。这种 M2 巨噬细胞的积累可能有助于先前观察到的脂肪组织在危重病中的保护性代谢活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9db/3334796/838b9aec322e/cc10503-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验